Starboard Value
Starboard Value LP is a New York-based investment adviser with a focused and differentiated fundamental approach to investing in publicly traded U.S. small cap companies. Starboard invests in deeply undervalued small cap companies and actively engages with management teams and boards of directors to identify and execute on opportunities to unlock value for the benefit of all shareholders.
View Older Stories View More Recent Stories
-
Form 13F-NT Starboard Value GP LLC For: Dec 31
-
Form 13F-HR Starboard Value LP For: Dec 31
-
ModivCare Inc. (MODV) Changed Board of Directors
-
Modivcare Announces Changes to Board of Directors
-
Riot Platforms appoints new directors to board with inputs from Starboard, D.E. Shaw
-
Riot Platforms Announces Changes to Its Board of Directors and Provides Update on Formal Evaluation of AI/HPC Uses
-
Kenvue sees 2025 profit below estimates as dollar strengthens
-
Kenvue Highlights Commitment to Shareholder Value
-
Starboard nominates four directors to Kenvue's board
-
Form PREC14A Kenvue Inc. Filed by: Starboard Value LP
-
Form SCHEDULE 13D/A Fortrea Holdings Inc. Filed by: Starboard Value LP
-
Exclusive-D.E. Shaw takes stake in bitcoin miner Riot Platforms, sources say
-
Activist investor Starboard Value takes 7.7% stake in chipmaker Qorvo
-
Form SCHEDULE 13D Qorvo, Inc. Filed by: Starboard Value LP
-
Stocks rally to close out strong week, await Trump policies
-
Starboard builds 7.7% stake in chipmaker Qorvo, WSJ reports
-
Starboard Value Builds 7.7% Qorvo Stake- WSJ
-
Pfizer to sell $3 billion stake in Sensodyne maker Haleon
-
Form SC 13D/A Alight, Inc. / Delaware Filed by: Starboard Value LP
-
Form SC 13D/A Healthcare Realty Trust Filed by: Starboard Value LP
-
Healthcare Realty Trust (HR) Announces Changes to Board of Directors, 3 New Directors
-
Healthcare Realty Trust Announces Changes to Board of Directors
-
Form SC 13D Healthcare Realty Trust Filed by: Starboard Value LP
-
News Corp says investors reject proposal to end dual class voting structure
-
Pfizer names oncology head Chris Boshoff as R&D chief
-
Form SC 13D/A ACACIA RESEARCH CORP Filed by: Starboard Value LP
-
Form 13F-NT Starboard Value GP LLC For: Sep 30
-
Form 13F-HR Starboard Value LP For: Sep 30
-
Exclusive-Pfizer explores sale of hospital drugs unit, sources say
-
Acacia Research Reports Third Quarter 2024 Financial Results
-
Form DFAN14A NEWS CORP Filed by: Starboard Value LP
-
Form DFAN14A NEWS CORP Filed by: Starboard Value LP
-
Leading Proxy Advisory Firms in the United States and Australia – ISS, Glass Lewis, Egan-Jones, and Ownership Matters – Unanimously Recommend Shareholders Vote FOR Starboard’s Proposal to Elimin
-
Kenvue's falling skin health sales hit earnings again
-
Match forecasts lackluster revenue as Tinder turnaround takes longer
-
Irenic Capital to Support Elimination of News Corp’s Dual-Class Share Structure
-
News Corp shareholders urged to end dual-class voting structure by more firms
-
ISS urges News Corp investors to back plan to collapse dual-class voting structure
-
Pfizer (PFE) Meeting With Starboard Was Constructive, Cordial - CEO Bourla
-
Pfizer CEO defends turnaround strategy as activist pressures management
-
Pfizer management looks to show turnaround as Starboard looms
-
Corvex founder Meister sees big upside for stocks already targeted by others
-
Starboard Value CEO says Pfizer's board should hold management accountable
-
Starboard Value Issues Presentation Delivered at 13D Monitor’s 2024 Active-Passive Investor Summit
-
Starboard says Kenvue's skin health segment weighing on performance
-
Starboard Value Issues Presentation Delivered at 13D Monitor’s 2024 Active-Passive Investor Summit
-
Starboard takes stake in consumer products maker Kenvue, sources say
-
Starboard Value Builds Stake In Tylenol-Maker Kenvue - WSJ
-
Pfizer taps Vanguard veteran for board amid fight with Starboard
-
BofA analysts say "infrequent customers" are hitting sales at this coffee chain

